are glp 1 safe How GLP-1s? Safety risks in the GLP-1

Omzo's own Terms explicitly state the platform "makes no claims that its compounded formulations are equivalent to, have the same active ingredient as, or will produce the same clinical outcomes as FDA-approved drugs." The active ingredient overlaps

Patients use Liraglutide Injection, a Glucagon-Like Peptide-1 (GLP-1) medication, along with diet and exercise to enhance glycemic control in adults and children aged 10 and up with type 2 diabetes

Risk of Parkinson disease in diabetes mellitus: An updated meta-analysis of population-based cohort studies

The maximum dose of semaglutide is 2 mg weekly for Ozempic, and 2.4 mg weekly for Wegovy

Accessed 22/2/2025 Nauck MA, Jensen TJ, Rosenkilde C, Calanna S, Buse JB

For weight management, the Food and Drug Administration (FDA) has approved two medications: Semaglutide (Wegovy) Tirzepatide (Zepbound) These drugs contain the same active ingredients as diabetes medications such as Ozempic and Mounjaro, but Wegovy and Zepbound are specifically approved for chronic weight management